Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies

por Goodstal, Samantha M., Lin, Jing, Crandall, Timothy, Crowley, Lindsey, Bender, Andrew T., Pereira, Albertina, Soloviev, Maria, Wesolowski, John S., Iadevaia, Riham, Schelhorn, Sven-Eric, Ross, Edith, Morandi, Federica, Ma, Jianguo, Clark, Anderson
Publicado 2023

Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses

por Lan, Yan, Yeung, Tsz-Lun, Huang, Hui, Wegener, Ansgar A, Saha, Somdutta, Toister-Achituv, Mira, Jenkins, Molly H, Chiu, Li-Ya, Lazorchak, Adam, Tarcic, Ohad, Wang, Hong, Qi, Jin, Locke, George, Kalimi, Doron, Qin, Guozhong, Marelli, Bo, Yu, Huakui, Gross, Alec W, Derner, Melissa G, Soloviev, Maria, Botte, Mathieu, Sircar, Aroop, Ma, Hong, Sood, Vanita D, Zhang, Dong, Jiang, Feng, Lo, Kin-Ming
Publicado 2022